Evidence map›Paper›PMID 33924029›Full record

ArticleVaccines2021

The Impact of an Inactivated Hepatitis A Vaccine with One Dose in Brazil: A Retrospective Time-Series.

Ana Luiza Bierrenbach, Yoonyoung Choi, Paula de Mendonça Batista, Fernando Brandão Serra, Cintia Irene Parellada, Guilherme Silva Julian, Karina Nakajima, Thais das Neves Fraga Moreira

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Ana Luiza BierrenbachInstituto de Ensino e Pesquisa, Hospital Sírio-Libanês, São Paulo 01308-050, SP, Brazil.ORCID 0000-0002-6837-0636
Yoonyoung ChoiMerck & Co., Inc., Kenilworth, NJ 07033, USA.
Paula de Mendonça BatistaMSD Brazil, São Paulo 04717-004, SP, Brazil.
Fernando Brandão SerraMSD Brazil, São Paulo 04717-004, SP, Brazil.
Cintia Irene ParelladaMSD Brazil, São Paulo 04717-004, SP, Brazil.ORCID 0000-0002-8536-9274
Guilherme Silva JulianIQVIA Brazil, São Paulo 04719-002, SP, Brazil.ORCID 0000-0002-3487-2240
Karina NakajimaIQVIA Brazil, São Paulo 04719-002, SP, Brazil.
Thais das Neves Fraga MoreiraMSD Brazil, São Paulo 04717-004, SP, Brazil.
Microsoft (Brazil) · BRHospital Sírio-Libanês · BRMerck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn 2014, a recommended one-dose of inactivated hepatitis A vaccine was included in the Brazilian National Immunization Program targeting children 12-24 months. This decision addressed the low to intermediate endemicity status of hepatitis A across Brazil and the high rate of infection in children and adolescents between 5 and 19 years old. The aim of the study was to conduct a time-series analysis on hepatitis A incidence across age groups and to assess the hepatitis A distribution throughout Brazilian geographic regions.

methodsAn interrupted time-series analysis was performed to assess hepatitis A incidence rates before (2010-2013) and after (2015-2018) hepatitis A vaccine program implementation. The time-series analysis was stratified by age groups while a secondary analysis examined geographic distribution of hepatitis A cases.

resultsOverall incidence of hepatitis A decreased from 3.19/100.000 in the pre-vaccine period to 0.87/100.000 (

conclusionOur study highlighted the positive impact of a recommended one-dose inactivated hepatitis A vaccine for 1-4-years-old in controlling hepatitis A at national level.

Indexed as

hepatitis Ainterrupted time-series analysisnational immunization program

Identifiers

PMID33924029
PMCPMC8072696
OpenAlexW3153894491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.